Database

Startups

Main Industry
Biotechnology
Main Product/Service
With expertise in neuroscience research and the development of bio-electronic medicine, our team has owned the core technologies, including proprietary wireless microchips for neuromodulation, algorithms for detecting pathological brain activities, shallow brain stimulation strategies, and a smart AIoT (AI and internet-of-things) system. We are on a mission to bring our success in building a perfect method to change the diagnosis and treatment of neurological disorders and beyond.
Founded Year
2018
Unified Business No.
42950523
Status
Active
Number of Employees
0
Total Paid-in Capital
82,518,860 (NT$)
Location of Company
Taiwan , Hsinchu City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
About the Company
BioPro Scientific offers wireless technologies, data acquisition, internet of things, chip design, material science, neuroscience, biotech, electrical engineering, biomedical engineering, in-situ, animal research, measuring instruments, and electrophysiology.



More ↓

Similar Companies

BIOLEGEND TAIWAN INC.

1. Antibodies and Reagents
2. Apoptosis and Cell Health Reagents
3. Buffers and Chemical Probes
4. Clinical | Analyte Specific Reagents (ASR)
5. Isotype Controls
6. Magnetic Separation - MojoSort?
7. Non-Human Primate Antibodies
8. Recombinant Proteins, Cytokines, Growth Factors
9. SARS-CoV-2 Reagents
10. Soluble MHC ? Flex?T?
11. Ultra-LEAF? | GoInVivo? Antibodies
12. Cell-Vive? GMP Portfolio

KONTEX INC.

Our initial product offerings reflect our commitment to quality and innovation, designed to support the neuroscience research community effectively. KONTEX is also focused on expanding the application of our technologies to clinical settings, aiming to make meaningful contributions to both research and healthcare.

?